Literature DB >> 21742614

Predictors of osteodystrophy in patients with chronic nonalcoholic pancreatitis with or without diabetes.

Krishna Sudeep1, Ashok Chacko, Nihal Thomas, Ratnasamy Selvakumar, Biju George, Thomas Vizhalil Paul, Mandalam S Seshadri.   

Abstract

OBJECTIVE: To study bone mineral content (BMC), bone mineral density (BMD), vitamin D status, and bone mineral variables in patients with chronic nonalcoholic pancreatitis and to determine the relationship between pancreatic dysfunction and these variables.
METHODS: Thirty-one eligible nonalcoholic men with proven chronic pancreatitis and 35 male control subjects were studied. Biochemical data, variables of malabsorption, and BMD of the lumbar spine were evaluated.
RESULTS: In patients with chronic pancreatitis, the mean body mass index (BMI) was 18.46 kg/m² and the median 25-hydroxyvitamin D value was 15.5 (range, 5.0 to 52.0) ng/mL. A T-score of less than -2.5 was found in a higher proportion of study patients (9 of 31, 29%) than of control subjects (3 of 35, 9%). BMI correlated significantly with BMC (r = 0.426; P = .017). There was an inverse correlation between stool fat and BMC (r = -0.47; P = .03) in patients with chronic pancreatitis and steatorrhea. There was no significant correlation between serum 25-hydroxyvitamin D or biochemical variables and BMD. Patients with steatorrhea had a significantly lower BMC than did those without steatorrhea, and this difference could not be accounted for by differences in BMI, presence of diabetes, or hypovitaminosis D.
CONCLUSION: Pancreatic osteodystrophy is a novel entity consisting of osteopenia, osteoporosis, and osteomalacia in patients with chronic pancreatitis. The inverse correlation between stool fat and BMC in patients with chronic pancreatitis, the strong positive correlation between BMI and BMC, and the lack of difference in BMC between subjects with vitamin D sufficiency and those with vitamin D deficiency suggest that long-standing malabsorption with attendant chronic undernutrition is the major factor contributing to the changes in BMC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742614     DOI: 10.4158/EP10410.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  6 in total

1.  Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis.

Authors:  Xin-Ying Tang; Nan Ru; Qing Li; Yang-Yang Qian; Hui Sun; Jia-Hui Zhu; Lin He; Yuan-Chen Wang; Liang-Hao Hu; Zhao-Shen Li; Wen-Bin Zou; Zhuan Liao
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

Review 2.  Bone disease in chronic pancreatitis.

Authors:  Awais Ahmed; Aman Deep; Darshan J Kothari; Sunil G Sheth
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

3.  Bone health assessment in clinical practice is infrequenty performed in patients with chronic pancreatitis.

Authors:  Allison Kanakis; Kishore Vipperla; Georgios I Papachristou; Randall E Brand; Adam Slivka; David C Whitcomb; Dhiraj Yadav
Journal:  Pancreatology       Date:  2020-07-25       Impact factor: 3.977

Review 4.  Vitamin D and Pancreatitis: A Narrative Review of Current Evidence.

Authors:  Fei Cai; Cheng Hu; Chan-Juan Chen; Yuan-Ping Han; Zi-Qi Lin; Li-Hui Deng; Qing Xia
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

5.  Vitamins D and K as Factors Associated with Osteopathy in Chronic Pancreatitis: A Prospective Multicentre Study (P-BONE Study).

Authors:  Serena Stigliano; Alexander Waldthaler; Emma Martinez-Moneo; Luana Lionetto; Stuart Robinson; Marko Malvik; Aleksandra Hedstrom; Aleksandra Kaczka; Marius Scholdei; Stephan Haas; Maurizio Simmaco; Gianfranco Delle Fave; Matthias Lohr; Peter Simon; Gabriele Capurso
Journal:  Clin Transl Gastroenterol       Date:  2018-10-15       Impact factor: 4.488

Review 6.  Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines.

Authors:  Mary E Phillips; Andrew D Hopper; John S Leeds; Keith J Roberts; Laura McGeeney; Sinead N Duggan; Rajesh Kumar
Journal:  BMJ Open Gastroenterol       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.